Fig. 6From: Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcomaConstruction of nomogram model. a Nomogram to predict the prognosis of osteosarcoma at 1-, 3- and 5-year based on the eight immune cell types. b, c, d Calibration curves to assess the accuracy of the nomogram at 1-, 3- and 5-year. e DCA curves assess the clinical value of nomograms. f Clinical impact curves evaluate the clinical impact of the nomogramBack to article page